Home page Description:
Drs. Charles Tator and Michael Tymianski among new appointments to Order of Canada.
Posted On: January 16, 2017
Image Caption:
Drs. Charles Tator (L) and Michael Tymianski (R).
On December 30th 2016, his Excellency the Right Honourable David Johnston, Governor General of Canada, announced 100 new appointments to the Order of Canada. Among them were Krembil Emeritus Scientist, Dr. Charles Tator and Krembil Senior Scientist, Dr. Michael Tymianski.
“I am delighted to recognize these new recipients of the Order of Canada in this milestone year. Besides marking Canada’s 150th anniversary, 2017 marks the 50th anniversary of the Order” said the Governor General.
Dr. Tator’s research program has made seminal contributions to our understanding of spinal cord injury. Over the last decade, he has been one of Canada’s leaders in concussion research, safety and prevention. He was promoted within the Order to Officer "for his advocacy as a world-renowned authority on concussions and for promoting increased safety in sports."
For the past 20 years, Dr. Tymianski has been developing a promising new drug, called NA-1, to prevent brain damage caused by a stroke. Currently, NA-1’s effectiveness is being evaluated in a Phase 3 clinical trial. He was made a Member of the Order of Canada in recognition of “his contributions to neuroscience, particularly through his leadership in investigating new mechanisms to protect the brain following a stroke."
The Order of Canada recognizes outstanding achievement, dedication to the community and service to the nation. Drs. Tator and Tymianski join the almost 7,000 people from all sectors of society who have been appointed to the Order since its creation in 1967.
“I am delighted to recognize these new recipients of the Order of Canada in this milestone year. Besides marking Canada’s 150th anniversary, 2017 marks the 50th anniversary of the Order” said the Governor General.
Dr. Tator’s research program has made seminal contributions to our understanding of spinal cord injury. Over the last decade, he has been one of Canada’s leaders in concussion research, safety and prevention. He was promoted within the Order to Officer "for his advocacy as a world-renowned authority on concussions and for promoting increased safety in sports."
For the past 20 years, Dr. Tymianski has been developing a promising new drug, called NA-1, to prevent brain damage caused by a stroke. Currently, NA-1’s effectiveness is being evaluated in a Phase 3 clinical trial. He was made a Member of the Order of Canada in recognition of “his contributions to neuroscience, particularly through his leadership in investigating new mechanisms to protect the brain following a stroke."
The Order of Canada recognizes outstanding achievement, dedication to the community and service to the nation. Drs. Tator and Tymianski join the almost 7,000 people from all sectors of society who have been appointed to the Order since its creation in 1967.